Access 2.8M+ Filings Sign Up Free
Medivir Logo

Medivir | MVIR - Profile, Filings, Stock Info & Investor Relations Data

Medivir | MVIR
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Pharmaceuticals
Country
Sweden
Founded
1988
Medivir (MVIR)

Company Profile

Website
Investor Relations

About Medivir

Medivir develops innovative drugs with a focus on cancer where the unmet medical needs are high. The drug candidates are directed toward indication areas where available therapies are limited or missing and there are great opportunities to offer significant improvements to patients.

Medivir is developing MIV-818, a pro-drug designed to selectively treat liver cancer cells and to minimize side effects. It has the potential to become the first liver-targeted, orally administered drug for patients with HCC.

Collaborations and partnerships are important parts of Medivir's business model, and the drug development is conducted either by Medivir or in partnership. Birinapant, a SMAC mimetic, is exclusively outlicensed to IGM Biosciences (Nasdaq: IGMS) to be developed in combination with IGM-antibodies for the treatment of solid tumors.

Headquarters

Box 1086
141 22, Huddinge
Sweden

Medivir (MVIR)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

Medivir (MVIR)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

↑
Fredrik Öberg (Other)
Buy SEK 77,000.00 SEK 0.77 15.11.22
↑
Jens Anders Fredrik Lindberg (Other)
Buy SEK 192,500.00 SEK 0.77 14.11.22
↑
Magnus Christensen (Other)
Buy SEK 115,500.00 SEK 0.77 14.11.22
↑
Jens Anders Fredrik Lindberg (Other)
Buy SEK 122,850.00 SEK 8.19 28.03.22
↑
Jens Anders Fredrik Lindberg (Other)
Buy SEK 80,000.00 SEK 8.00 25.03.22
↑
Magnus Christensen (Other)
Buy SEK 46,800.00 SEK 7.80 03.03.22
↑
Malene Jensen (Other)
Buy SEK 25,650.00 SEK 1.71 23.12.21
↑
Malene Jensen (Other)
Buy SEK 109,500.00 SEK 2.19 13.12.21
↑
Malene Jensen (Other)
Buy SEK 85,500.00 SEK 1.71 13.12.21
↑
Fredrik Öberg (Other)
Buy SEK 97,500.00 SEK 1.00 13.05.21

Medivir (MVIR)
Stock & Investor Information

ISINs

SE0000325151
SE0000325169
SE0020181014
SE0020203115
US58502Y1064

LEI

549300VWDGUX0WMJ1T79

Stock Exchange Listings

Nasdaq Stockholm

Industry Classification

Sector
Health Care
Industry
Pharmaceuticals